Sector

IndusInd Bank Q1 FY26 -- The worst may be behind, but is it worth waiting for the best?

In view of the slack in loan growth, especially in the unsecured high-yield business, the bank is growing its deposits cautiously, de-focusing on high cost bulk deposits, and focusing on granular deposits

Kotak Mahindra Bank Q1 FY26: a blip not a blow

The bank had an unpleasant start to FY26

Brigade Hotel Ventures: Does the IPO offer a good investment opportunity?

The hotelier’s return ratios are solid and the stock valuation is attractive while part of the IPO money will support growth plans

Zensar Q1 FY26: A quarter of good execution

The key market of the US, and the turnaround in the TMT vertical aided revenue

Chart of the Day: A welcome relief for thermal power producers

Companies faced difficulty in rapidly installing pollution control systems

Cohance Lifesciences Q1 PAT may dip 64.2% YoY to Rs 51.6 cr: ICICI Securities

Net Sales are expected to decrease by 34.3 percent Y-o-Y (up 13.2 percent Q-o-Q) to Rs 552.4 crore, according to ICICI Securities.

HCL Tech Q1 FY26: Short-term pain for long-term gain

Margins took a hit because of the company’s investments for the future

Chart of the Day: India’s hard to ignore cost advantage in global pharma outsourcing

Cost competitiveness and diversification of global supply chains are helping India emerge as a major country in contract research and manufacturing services business

Data Story: Hindustan Aeronautics trumps Bharat Electronics in order book but lags in cash conversion

Order book at Hindustan Aeronautics doubled in FY25

Pressure builds on Indian pharma as Trump threatens massive tariffs

Indian drug exporters have been on a wait and watch mode till now

Gold companies post shining performance in Q1 FY26

Regulatory moves and consumer preference for branded products among factors helping companies like Titan, Senco Gold, and Sky Gold

Chart of the Day: India’s defence stocks dwarf global peers on valuations

Valuations of Hindustan Aeronautics, Bharat Electronics, Bharat Dynamics, Cochin Shipyard have increased significantly

Impending jump in patent expiries to benefit Indian pharma

Many drugs with large market potential are expected to lose exclusivity in the next couple of years

For Tata Chemicals, steady India demand can bring limited relief

Soda ash, a key product of Tata Chemicals, is seeing excess supplies and soft demand in global markets

Gabriel India: Unlocking new doors of opportunities

The company recently announced a demerger scheme. This move will transform Gabriel from a single product company into a highly diversified mobility solutions provider.

Optimism low on this healthcare stock

Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited

How is the health of this healthcare stock?

Timely execution and ramp-up of new projects are crucial for faster growth

India a bright spot for solar module manufacturers amid global uncertainty

The demand for locally made solar modules is expected to rise significantly in India

This hospital chain is aiming for high growth, but is it already priced in?

Max is on an aggressive expansion path with healthy medium-term growth visibility

Steep taxes can blunt premium play of alcohol companies

New taxes make premium products even more expensive for consumers

Chart of the Day: Price hikes remain key driver of Indian pharma market

The volume contribution to market growth has been low for more than a year now

Apollo Hospitals: Annual report card ticks all the right boxes

Robust expansion plans in place with the target to add a total of about 4000 beds in the next 3-4 years

The impact of mild summer season on NTPC

Electricity demand slowed considerably in April-May this year

Data Story: Private hospitals are making bold capacity expansion plans

Large hospital companies have laid out plans to significantly expand their bed capacity over the next 3-4 years